Approvals/TGA/APO-DROSPIRENONE/EE 3/20 drospirenone 3 mg and ethinylestradiol 20 microgram film-coated tablet blister pack

Approved

STANDARD

APO-DROSPIRENONE/EE 3/20 drospirenone 3 mg and ethinylestradiol 20 microgram film-coated tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 27d7acd68364d7c3
Product Name: APO-DROSPIRENONE/EE 3/20 drospirenone 3 mg and ethinylestradiol 20 microgram film-coated tablet blister pack
Artg Id: 200630
Artg Name: APO-DROSPIRENONE/EE 3/20 drospirenone 3 mg and ethinylestradiol 20 microgram film coated tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2013-07-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

27d7acd68364d7c3

Type

Standard